Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.35 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.35 |
| ▸ | LAP3 | P28838 | 1/20 | 0.34 |
| ▸ | GCLC | P48506 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL876782 | 0.83 | LAP3 (0.42) | GABBR2GABBR1LAP3CA12CA1 | |
| SCHEMBL16163266 | 0.79 | FDPS (0.45) | GABBR2GABBR1LAP3FDPS | |
| SCHEMBL5030278 | 0.74 | FDPS (0.46) | LAP3CA12CA1CA2MMP1 | |
| SCHEMBL16163115 | 0.74 | GCLC (0.36) | GABBR2GABBR1LAP3GCLCFDPS | |
| SCHEMBL339100 | 0.71 | FOLH1 (0.38) | LAP3CA12CA1CA2MMP1 | |
| SCHEMBL16163356 | 0.71 | GABBR2 (0.47) | GABBR2GABBR1FDPS | |
| SCHEMBL2404471 | 0.70 | — | — | |
| SCHEMBL16163412 | 0.70 | LPAR3 (0.45) | GABBR2GABBR1 | |
| SCHEMBL16163129 | 0.69 | LPAR3 (0.48) | FDPS | |
| SCHEMBL1359075 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2791152-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND DIALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2018-11-07 | — | — | EP | claimed |
| EP-2791149-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND ALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2017-06-14 | — | — | EP | claimed |
| US-20150005421-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-01-01 | — | — | US | claimed |
| US-20140329933-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2014-11-06 | — | — | US | claimed |
| US-20140309339-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-10-16 | — | — | US | claimed |
| EP-2791152-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND DIALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2018-11-07 | — | — | EP | disclosed |
| US-20180030355-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2018-02-01 | — | — | US | disclosed |
| US-20170313942-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2017-11-02 | — | — | US | disclosed |
| EP-2791149-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND ALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2017-06-14 | — | — | EP | disclosed |
| US-20150005421-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-01-01 | — | — | US | disclosed |
| US-20140329933-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2014-11-06 | — | — | US | disclosed |
| US-20140309339-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030355-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | PHOSPHO1, ENPP2, INPPL1 | GABBR2 2790/4885GABBR1 3342/4885LAP3 1277/4885 |
| US-20170313942-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | C3AR1, DCPS, ENPP2 | GABBR2 2368/4885GABBR1 2860/4885LAP3 972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.